Antithrombotic Therapy at the End of Life: The PEACE Study

Institute of Hospitalization and Scientific Care (IRCCS)

Status: Not yet enrolling

Conditions: Palliative Care

Treatments: Drug: antithrombotic drugs

Study type: Observational

Funder types: Other

Identifiers

NCT07338071

ID 3722

Details and patient eligibility

About

"Antithrombotic Therapy at the End of Life: The PEACE Study" is a multicenter, non-profit, cross-sectional observational study. In the absence of shared guidelines, therapeutic decisions on antithrombotic drugs vary significantly according to healthcare professional training and national context, resulting in marked variability in prescribing practices. This study aims to describe the prevalence of antithrombotic prescriptions in patients referred to Palliative Care.

Enrollment: 410 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Adults (≥18 years) hospitalized and referred to Palliative Care (home-based or residential) at the discretion of the attending physician.
• Signed informed consent

Exclusion criteria

• none